Cutaneous Manifestations of Methotrexate-associated Lymphoproliferative Disorders: Report of Two Cases and a Review of the Literature
Overview
Authors
Affiliations
Nocco S, Magro C Am J Dermatopathol. 2025; 47(2):145-152.
PMID: 39851907 PMC: 11776889. DOI: 10.1097/DAD.0000000000002905.
Kositkuljorn C, Rutnin S, Rattananukrom T, Puavilai T, Khiankaew B, Boonsakan P Clin Cosmet Investig Dermatol. 2023; 16:2229-2235.
PMID: 37601419 PMC: 10439773. DOI: 10.2147/CCID.S419534.
Delaleu J, Maubec E, Rodrigues F, Levy A, Szablewski V, Laroche L Acta Derm Venereol. 2020; 100(15):adv00226.
PMID: 32516423 PMC: 9207630. DOI: 10.2340/00015555-3554.
Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Tokuhira M, Tamaru J, Kizaki M J Clin Exp Hematop. 2019; 59(2):72-92.
PMID: 31257348 PMC: 6661962. DOI: 10.3960/jslrt.19007.
Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features.
Namiki T, Sone Y, Miura K, Tanaka M, Yokozeki H Case Rep Dermatol. 2018; 10(2):149-153.
PMID: 29928205 PMC: 6006657. DOI: 10.1159/000489694.